Sodium lactate - PharmaKB

Sodium lactate

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

4895 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Leukemia	D007938	—	C95	180	300	56	5	28	489
Lymphoma	D008223	—	C85.9	127	231	36	6	29	365
Type 2 diabetes mellitus	D003924	EFO_0001360	E11	47	37	131	91	57	359
Diabetes mellitus	D003920	EFO_0000400	E08-E13	23	40	129	78	37	299
Syndrome	D013577	—	—	65	133	33	23	43	266
Myelodysplastic syndromes	D009190	—	D46	77	146	17	1	16	225
Myeloid leukemia	D007951	—	C92	85	122	19	1	8	201
Myeloid leukemia acute	D015470	—	C92.0	85	113	21	1	8	196
Lymphoid leukemia	D007945	—	C91	62	116	33	2	9	191
Preleukemia	D011289	—	—	61	121	13	1	14	185

Show 608 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Plasma cell neoplasms	D054219	—	—	36	61	2	—	13	101
Hodgkin disease	D006689	—	C81	26	65	11	—	7	92
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	20	67	4	—	4	84
Lung neoplasms	D008175	—	C34.90	17	36	19	—	2	68
Hematologic neoplasms	D019337	—	—	31	40	3	—	4	67
Myelodysplastic-myeloproliferative diseases	D054437	—	—	15	42	5	—	7	63
Follicular lymphoma	D008224	—	C82	25	40	4	—	7	63
Mantle-cell lymphoma	D020522	—	C83.1	28	38	3	—	6	62
Graft vs host disease	D006086	—	D89.81	11	41	9	—	3	57
Small cell lung carcinoma	D055752	—	—	15	31	14	—	1	56

Show 345 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Plasmacytoma	D010954	—	C90.3	16	32	—	—	9	53
B-cell lymphoma marginal zone	D018442	—	C88.4	14	25	—	—	7	40
T-cell lymphoma cutaneous	D016410	—	C84.A	9	17	—	—	7	29
Myeloid leukemia accelerated phase	D015465	—	—	5	21	—	—	3	27
Mycosis fungoides	D009182	—	C84.0	9	16	—	—	6	27
Lymphomatoid granulomatosis	D008230	—	C83.8	8	17	—	—	6	27
T-cell leukemia	D015458	—	—	7	17	—	—	5	26
Sezary syndrome	D012751	—	C84.1	7	15	—	—	6	25
Adult t-cell leukemia-lymphoma	D015459	—	C91.5	5	14	—	—	5	22
Blast crisis	D001752	—	—	4	15	—	—	1	18

Show 313 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Tissue adhesions	D000267	—	—	1	—	—	—	6	7
Pruritus	D011537	—	L29	2	—	—	—	3	5
Impacted tooth	D014095	—	K01.1	1	—	—	—	4	5
Hyperlactatemia	D065906	—	—	1	—	—	—	3	4
Drug interactions	D004347	—	—	2	—	—	—	1	3
Skin aging	D015595	EFO_0005422	—	1	—	—	—	2	3
Xerostomia	D014987	—	K11.7	1	—	—	—	2	3
Papillomavirus infections	D030361	—	—	1	—	—	—	1	2
Papilledema	D010211	EFO_1001074	H35.81	1	—	—	—	1	2
Gastrointestinal neoplasms	D005770	—	C26.9	1	—	—	—	1	2

Show 96 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Peri-implantitis	D057873	EFO_1001390	—	—	—	—	—	5	5
Sinus floor augmentation	D059546	—	—	—	—	—	—	5	5
Graves disease	D006111	EFO_0004237	E05.0	—	—	—	—	3	3
Familial hypophosphatemia	D007015	—	E83.31	—	—	—	—	3	3
Acid-base imbalance	D000137	—	—	—	—	—	—	3	3
Flatfoot	D005413	EFO_0003874	M21.4	—	—	—	—	3	3
Mycoplasma pneumonia	D011019	EFO_0007387	J15.7	—	—	—	—	2	2
Mycoplasma pneumoniae	D009177	—	B96.0	—	—	—	—	2	2
Mycoplasma infections	D009175	—	—	—	—	—	—	2	2
Pleuropneumonia	D011001	—	—	—	—	—	—	2	2